Results 31 to 40 of about 29,426 (209)

Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis

BMJ Open, 2019
Objective Evaluate effectiveness, harms and burdens of faecal blood testing, sigmoidoscopy and colonoscopy screening for colorectal cancer over 15 years.Design We performed an update of a Cochrane systematic review, and performed network meta-analysis ...
Per Olav Vandvik, Lyubov Lytvyn, Joseph C Anderson, Lise M Helsingen, Henriette C Jodal, Louise Emilsson   +5 more
doaj   +1 more source

Efficacy of sigmoidoscopy for evaluating disease activity in patients with ulcerative colitis

BMC Gastroenterology, 2022
Background Endoscopic assessment of disease activity is a key parameter in the management of ulcerative colitis. Whether sigmoidoscopy alone is sufficient to evaluate the disease activity in ulcerative colitis lacks studies.
Su Bum Park, Seong-Jung Kim, Jun Lee, Yoo Jin Lee, Dong Hoon Baek, Geom Seog Seo, Eun Soo Kim, Sang-Wook Kim, So Yeong Kim   +8 more
doaj   +1 more source

General populations’ preferences for colorectal cancer screening: rationale and protocol for the discrete choice experiment in the SIGMO study

BMJ Open, 2021
Introduction In Germany, the organised colorectal cancer (CRC) screening programme includes the immunologic faecal occult blood test and colonoscopy.
Jona Theodor Stahmeyer, Melanie Brinkmann, Leonie Diedrich, Christian Krauth, Bernt-Peter Robra, Maren Dreier   +5 more
doaj   +1 more source

The B-ADENOMA Study: Bowelscope – Accuracy of Detection using Endocuff Optimisation of Mucosal Abnormalities: Study Protocol for randomised controlled trial

Endoscopy International Open, 2018
Background and study aims UK Bowel Cancer Screening flexible sigmoidoscopy (BowelScope) currently offers patients aged 55 a one-off flexible sigmoidoscopy for adenoma clearance to decrease colorectal cancer incidence by interrupting the adenoma-carcinoma
Wee Sing Ngu, Martin Walls, Pradeep Bhandari, Clive Stokes, Nikki Totton, Zoe Hoare, Lexi Bastable, Colin Rees   +7 more
doaj   +1 more source

Promotion and provision of colorectal cancer screening: a comparison of colorectal cancer control program grantees and nongrantees, 2011-2012. [PDF]

, 2014
IntroductionSince 2009, the Centers for Disease Control and Prevention (CDC) has awarded nearly $95 million to 29 states and tribes through the Colorectal Cancer Control Program (CRCCP) to fund 2 program components: 1) providing colorectal cancer (CRC ...
DeGroff, Amy, Escoffery, Cam, Hannon, Peggy A, Kohn, Marlana, Maxwell, Annette E, Vernon, Sally W, Vu, Thuy   +6 more
core   +2 more sources

Indicators to identify cancer screening providers with suboptimal case detection: A scoping review

International Journal of Cancer, EarlyView.
What's New? Quality control of cancer screening programs is essential to maintaining high public health standards. Here, the authors reviewed monitoring of case detection in cervical and colorectal cancer screening programs in Europe, and evaluated its effectiveness. They analysed 20 different measures used for this purpose and showed that many of them
Jiayao Lei, Milena Falcaro, Adam R. Brentnall, James F. O'Mahony, Sisse Helle Njor, Matejka Rebolj   +5 more
wiley   +1 more source

Case of Pseudomembranous Colitis Caused by a Clostridioides difficile Infection Concomitant with Cytomegalovirus colitis Mimicking Ischemic Colitis

The Korean Journal of Gastroenterology, 2023
A Clostridioides difficile infection (CDI) is one of the major nosocomial diarrheal diseases. Pseudomembranous colitis (PMC) is a characteristic endoscopic finding of CDI, manifested by white or yellowish plaque covering the colonic mucosa.
Hyo Suk Kim, Hye Min Kim, Tae-Geun Gweon
doaj   +1 more source

Reshaping study design for faster extrapolation‐based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN–NASPGHAN position paper

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Children with inflammatory bowel diseases (IBD) have limited access to the available advanced therapies, given the lengthy gap between adult and pediatric approval. We aimed to review key hurdles for pediatric trials and recommend practical solutions.
Dan Turner, Amit Assa, Mikkel Malham, Shira Yuval Bar‐Asher, Carla Rayan, Jeffrey S. Hyams, Holm H. Uhlig, Brad Pasternak, David C. Wilson, Hilary K. Michel, Lissy de Ridder, Eric Zuckerman, Marina Aloi, Peter Szitanyi, Marla C. Dubinsky, Anne M. Griffiths, Roberto Saldana, Javier Martín‐de‐Carpi, Eytan Wine, Richard K. Russell, Jeremy Adler, Joseph Picoraro   +21 more
wiley   +1 more source

Colorectal Cancer Screening [PDF]

, 2017
The USPSTF gives Colorectal Cancer screening a Grade A recommendation, beginning at age 50 years and continuing until age 75 years. Screening colonoscopies are proven to show dramatic decreased incidence and mortality from colorectal cancer. This project
Schmidt, Eric
core   +2 more sources

Costs of Finding an Advanced Adenoma in Colorectal Screening

Canadian Journal of Gastroenterology, 2004
The authors used computerized decision analysis to estimate the costs of finding and removing an advanced colonic adenoma in patients referred because of a positive fecal occult blood test.
Jerome B Simon
doaj   +1 more source